Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
3M
3M and VaxInnate Collaborate to Develop Flu Vaccine Patch
November 7th, 2008
3M Drug Delivery Systems has entered into an agreement with VaxInnate Corporation to develop a flu vaccine patch for use against a pandemic flu outbreak. The non-exclusive license agreement provides VaxInnate with use of patented 3M microneedle technology, called 3M Microstructured Transdermal System (MTS) technology, to deliver its M2e universal flu vaccine using a convenient skin patch instead of a traditional injection. 3M's innovative microneedle technology penetrates the skin with minimal discomfort, providing intradermal delivery for drugs, vaccines and protein therapeutics that are typically available only via injection. This application expands the range of...
Source: Health Business Week (2008-11-07)
|
